Edition:
United States

Ampio Pharmaceuticals Inc (AMPE.A)

AMPE.A on American Stock Exchange

0.98USD
9 Dec 2016
Change (% chg)

$0.00 (+0.42%)
Prev Close
$0.97
Open
$0.99
Day's High
$0.99
Day's Low
$0.95
Volume
60,652
Avg. Vol
42,157
52-wk High
$4.32
52-wk Low
$0.59

AMPE.A

Chart for AMPE.A

About

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for... (more)
No analyst recommendations are available for AMPE.A.

Overall

Beta: 0.31
Market Cap(Mil.): $55.76
Shares Outstanding(Mil.): 57.18
Dividend: --
Yield (%): --

Financials

  AMPE.A Industry Sector
P/E (TTM): -- 41.98 30.40
EPS (TTM): -0.49 -- --
ROI: -80.03 -0.36 15.24
ROE: -94.39 -0.94 16.58

BRIEF-Ampio Pharmaceuticals qtrly loss per share $0.07

* Qtrly loss per share $0.07 - SEC filing Source text (http://bit.ly/2eIEiiR) Further company coverage:

Nov 08 2016

BRIEF-Ampio Pharmaceuticals announces pricing of registered direct offering

* Ampio Pharmaceuticals, Inc. announces pricing of registered direct offering

Aug 29 2016

BRIEF-Ampio Pharmaceuticals updates regulatory status of Ampion

* Has filed a meeting request with FDA to seek guidance on filing of co's biological license application for Ampion

Aug 03 2016

Competitors

Earnings vs. Estimates